Target intelligence / Profile preview

P-fimbrial lectin adhesin (PapG)

Target
PapG
Molecular classification
Lectin, Adhesin, Bacterial surface protein, Pilus protein
01

Overview

P-fimbrial lectin adhesins, primarily the PapG protein, are critical virulence factors located at the distal tips of P-pili (pyelonephritis-associated pili) in uropathogenic Escherichia coli (UPEC) [1, 5]. These adhesins function as lectins that specifically recognize and bind to the Gal(alpha1-4)Gal carbohydrate moiety found in the P-blood group antigens and globoseries glycolipids on host cell surfaces [1, 12]. This interaction is a critical first step in the pathogenesis of upper urinary tract infections, as it allows UPEC to colonize the renal pelvis and kidney parenchyma, leading to acute pyelonephritis [16]. There are three main alleles of PapG (I, II, and III), with PapG-II being the most prevalent in human pyelonephritis cases due to its high affinity for globoside (Gb4) in the human kidney [6]. Beyond adhesion, PapG has been shown to protect the bacteria from neutrophil bactericidal activity, further contributing to its role in immune evasion [7]. Because these adhesins are vital for establishing infection but not for bacterial survival, they are considered prime targets for anti-virulence strategies [14]. Therapeutic approaches include synthetic galabiose-based inhibitors that competitively block the binding site and vaccines like the PapDG subunit vaccine designed to elicit protective antibodies [1, 9]. These anti-adhesive molecules offer a promising alternative to traditional antibiotics, potentially reducing the selective pressure for drug resistance while specifically targeting pathogenic strains [3, 14].

Other names
PapG adhesinP-fimbriae adhesinGal-Gal binding adhesinPyelonephritis-associated pilus G proteinP-pilus adhesinGal(alpha1-4)Gal-specific tip adhesin
02

Mechanism of action

Inhibition of bacterial attachment to host uroepithelial cells by competitively binding to Gal(alpha1-4)Gal-containing glycolipid receptors.

03

Biological functions

Bacterial adhesionHost cell colonizationBiofilm formationImmune evasion
04

Disease associations

Urinary tract infectionPyelonephritisCystitisBacteremia
05

Safety considerations

Potential impact on commensal E. coliDevelopment of bacterial resistance to anti-virulence agentsTargeting specificity across different PapG alleles (I, II, III)
06

Interacting drugs

Galabiose derivatives

2 more in the full profile.

07

Biomarkers

papG gene expressionMannose-resistant hemagglutination (MRHA)P-fimbriae presence in clinical isolates

Beyond the preview

Go deeper on P-fimbrial lectin adhesin (PapG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on P-fimbrial lectin adhesin (PapG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call